Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ALEXION PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: ALXN

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 1.750 Buy 16
    30 Days Ago 1.667 Buy 15
    60 Days Ago 1.800 Buy 15
    90 Days Ago 1.813 Buy 16
    120 Days Ago 1.600 Buy 15

  • Analyst Ratings: ALXN

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Jefferies & Co — Buy 10/08/2009 49.00
    Brean Murray — Buy 07/23/2009 46.00
    ThinkEquity — Sell 07/16/2009 28.00
    Brean Murray — Buy 03/19/2009 42.00
    FTN Equity Capital — Buy 03/12/2009 —
    Needham — Buy 02/18/2009 51.00
    Credit Suisse — Outperform 02/13/2009 53.00
    Leerink Swann — Outperform 02/09/2009 —
    Banc of America Sec — Buy 08/14/2008 110.00
    UBS — Buy 07/31/2008 100.00
    Jefferies & Co — Buy 07/30/2008 100.00
    Collins Stewart — Buy 07/25/2008 95.00
    Piper Jaffray — Buy 05/29/2008 88.00
    Jefferies & Co — Buy 05/14/2008 89.00
    UBS — Buy 02/15/2008 86.00
    Wachovia Outperform Mkt Perform 02/15/2008 —
    UBS — Buy 01/29/2008 82.00
    Credit Suisse Neutral Outperform 10/26/2007 —
    Broadpoint Capital — Buy 10/26/2007 86.00
    Ferris Baker Watts — Buy 10/12/2007 85.00
    Banc of America Sec — Buy 10/05/2007 —
    Cowen & Co — Outperform 08/08/2007 —
    Credit Suisse Outperform Neutral 08/08/2007 —
    First Albany — Buy 07/26/2007 68.00
    First Albany Neutral Buy 03/16/2007 47.00
    First Albany Buy Neutral 02/16/2007 —
    Goldman Sachs — Neutral 12/04/2006 —
    Credit Suisse — Outperform 11/06/2006 49.00
    Piper Jaffray — Outperform 04/05/2006 51.00
    Harris Nesbitt Outperform Neutral 11/23/2005 20.00
    Next